MwanzoNSIS-B • CPH
add
Novozymes A/S
Bei iliyotangulia
kr 475.90
Bei za siku
kr 474.70 - kr 480.40
Bei za mwaka
kr 375.90 - kr 480.40
Thamani ya kampuni katika soko
192.02B DKK
Wastani wa hisa zilizouzwa
elfu 557.47
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
CPH
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 915.85M | 61.70% |
Matumizi ya uendeshaji wa biashara | 271.75M | 52.62% |
Mapato halisi | 31.95M | -60.72% |
Kiwango cha faida halisi | 3.49 | -75.70% |
Mapato kwa kila hisa | — | — |
EBITDA | 150.94M | -16.50% |
Asilimia ya kodi ya mapato | 29.00% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 260.80M | 85.35% |
Jumla ya mali | 15.25B | 302.43% |
Jumla ya dhima | 4.25B | 119.23% |
Jumla ya hisa | 11.00B | — |
hisa zilizosalia | 277.90M | — |
Uwiano wa bei na thamani | 12.02 | — |
Faida inayotokana na mali | 1.83% | — |
Faida inayotokana mtaji | 2.15% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 31.95M | -60.72% |
Pesa kutokana na shughuli | 264.05M | 74.01% |
Pesa kutokana na uwekezaji | -27.45M | 70.98% |
Pesa kutokana na ufadhili | -186.70M | -205.10% |
Mabadiliko halisi ya pesa taslimu | 55.55M | 902.56% |
Mtiririko huru wa pesa | -17.57M | 68.87% |
Kuhusu
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange.
On 12 December 2023, it was announced that Nozozymes and Danish bioscience company Chr. Hansen had obtained regulatory approval for a merger, and on the following day, the name of the combined company was revealed as Novonesis. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2000
Tovuti
Wafanyakazi
10,452
